Robotic IVC thrombectomy — the removal of cancer from the inferior vena cava — is not inferior to standard open IVC thrombectomy and is a highly safe and effective alternative approach, researchers have found.
Read More ›
UT Health San Antonio is investing $5 million over the next three years in cryo-electron microscopy, or cryo-EM for short. Cryo-EM visualizes proteins that are extremely difficult to image using other techniques.
One-fifth of babies who inherit a genetic variant located on chromosome 16 will develop autism spectrum disorder by age 3. The variant is called 16p11.2 deletion.
In a breakthrough finding, scientists discovered that inhibiting a liver enzyme in obese mice decreased the rodents’ appetites, increased energy expenditure in fat tissues and resulted in weight loss. The finding provides a potential drug target to treat metabolic issues such as obesity and diabetes.
Having at least some omega-3s in red blood cells was associated with better brain structure and cognitive function among healthy study volunteers in their 40s and 50s, according to research published online Oct. 5 in Neurology, the medical journal of the American Academy of Neurology. Faculty of UT Health San Antonio and other investigators of the Framingham Heart Study conducted the analysis.
Because of international collaboration, more genetic variations for Alzheimer’s disease are known today than ever before.
The first therapy developed for post-traumatic headache significantly reduced related disability in veterans following a traumatic brain injury and decreased co-occurring symptoms of post-traumatic stress disorder.
A $2.5 million Trauma Research and Combat Casualty Care Collaborative at UT Health San Antonio will be the first and only of its kind in the U.S. It is a partnership with the Department of Defense and University Health’s Level 1 Trauma Center at University Hospital.
As researchers and physicians battle against an unpredictable, incurable foe, one patient refuses to let multiple sclerosis defeat her.
A type of cellular stress known to be involved in cancer and aging has now been implicated, for the first time, in Alzheimer’s disease.